Moon J
Encephalitis. 2023; 2(2):29-35.
PMID: 37469651
PMC: 10295911.
DOI: 10.47936/encephalitis.2021.00164.
Lindahl H, Bryceson Y
Front Immunol. 2022; 12:827815.
PMID: 35126383
PMC: 8807658.
DOI: 10.3389/fimmu.2021.827815.
Mulazzani E, Wagner D, Havla J, Schluter M, Meinl I, Gerdes L
J Neuroinflammation. 2020; 17(1):196.
PMID: 32563262
PMC: 7306142.
DOI: 10.1186/s12974-020-01867-5.
Cocho L, Urbaneja E, Herreras J
Int Ophthalmol. 2017; 39(1):219-223.
PMID: 29256170
DOI: 10.1007/s10792-017-0785-y.
Menon S, Efthimiou P
Rheumatol Int. 2017; 38(1):3-11.
PMID: 28942479
DOI: 10.1007/s00296-017-3820-4.
Obsessive-Compulsive Disorder, Tics, and Autoinflammatory Diseases: Beyond PANDAS.
Garcia-Delgar B, Morer A, Luber M, Coffey B
J Child Adolesc Psychopharmacol. 2016; 26(9):847-850.
PMID: 27854543
PMC: 6445174.
DOI: 10.1089/cap.2016.29118.bjc.
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.
Bascherini V, Granato C, Lopalco G, Emmi G, Vannozzi L, Bacherini D
Clin Rheumatol. 2015; 34(7):1171-80.
PMID: 25833143
DOI: 10.1007/s10067-015-2920-3.
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.
Rigante D, Lopalco G, Vitale A, Lucherini O, De Clemente C, Caso F
Clin Rheumatol. 2014; 33(9):1197-207.
PMID: 24935411
DOI: 10.1007/s10067-014-2722-z.
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Ottoboni L, Frohlich I, Lee M, Healy B, Keenan B, Xia Z
Neurology. 2013; 81(22):1891-9.
PMID: 24174586
PMC: 3843384.
DOI: 10.1212/01.wnl.0000436612.66328.8a.
Monogenic autoinflammatory diseases: concept and clinical manifestations.
de Jesus A, Goldbach-Mansky R
Clin Immunol. 2013; 147(3):155-74.
PMID: 23711932
PMC: 3769788.
DOI: 10.1016/j.clim.2013.03.016.
Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
Caminero A, Comabella M, Montalban X
Clin Exp Immunol. 2011; 166(3):338-45.
PMID: 22059991
PMC: 3232381.
DOI: 10.1111/j.1365-2249.2011.04484.x.
TNFRSF1A [corrected] R92Q mutation, autoinflammatory symptoms and multiple sclerosis in a cohort from Argentina.
Kauffman M, Gonzalez-Moron D, Garcea O, Villa A
Mol Biol Rep. 2011; 39(1):117-21.
PMID: 21567205
DOI: 10.1007/s11033-011-0716-3.
Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site.
Lehmann P, Salzberger B, Haerle P, Aksentijevich I, Kastner D, Schoelmerich J
Mod Rheumatol. 2010; 20(3):311-5.
PMID: 20169391
PMC: 3074501.
DOI: 10.1007/s10165-010-0273-y.
The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis.
Jenne D, Aries P, Einwachter S, Akkad A, Wieczorek S, Lamprecht P
Ann Rheum Dis. 2007; 66(9):1266-7.
PMID: 17693606
PMC: 1955148.
DOI: 10.1136/ard.2006.065987.
Hereditary auto-inflammatory disorders and biologics.
Church L, Churchman S, Hawkins P, McDermott M
Springer Semin Immunopathol. 2006; 27(4):494-508.
PMID: 16738958
DOI: 10.1007/s00281-006-0015-6.
[Tumour necrosis factor receptor-associated periodic syndrome. A rare differential diagnosis of multiple sclerosis].
Gunther P, Minden K, Hermann W, Schneider J, Wagner A
Nervenarzt. 2005; 76(10):1263-6.
PMID: 15834693
DOI: 10.1007/s00115-005-1906-9.
